Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K W To

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Medicinal Research Reviews|June 6, 2003
Platinum-based anticancer agents: innovative design strategies and biological perspectivesYee-Ping Ho, Steve C F Au-Yeung, Kenneth K W To
Cancer Letters|May 18, 2005
Synergistic interaction between platinum-based antitumor agents and demethylcantharidinKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Anti-Cancer Drugs|August 13, 2005
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agentsKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 2, 2021
The prospects of tumor chemosensitivity testing at the single-cell levelChuan Yang, Caibo Yang, Yosef Yarden, et al.
Anti-Cancer Drugs|August 19, 2006
Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophilesKenneth K W To, Steve C F Au-Yeung, Yee-Ping Ho
Journal of Chromatography. A|March 12, 2002
Determination of the release of hydrolyzed demethylcantharidin from novel traditional chinese medicine-platinum compounds with anticancer activity by gas chromatographyKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Expert Opinion on Drug Metabolism & Toxicology|November 25, 2010
The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statinsMiao Hu, Kenneth K W To, Valiant W L Mak, et al.
Molecules (Basel, Switzerland)|April 13, 2023
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic ApplicationsKenneth K W To, Enming Xing, Ross C Larue, et al.
Molecular Carcinogenesis|June 17, 2011
Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cellsKenneth K W To, Le Yu, Shuwen Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 26, 2024
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapyKenneth K W To, Zoufang Huang, Hang Zhang, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Medicinal Research Reviews|June 6, 2003
Platinum-based anticancer agents: innovative design strategies and biological perspectivesYee-Ping Ho, Steve C F Au-Yeung, Kenneth K W To
Cancer Letters|May 18, 2005
Synergistic interaction between platinum-based antitumor agents and demethylcantharidinKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Anti-Cancer Drugs|August 13, 2005
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agentsKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 2, 2021
The prospects of tumor chemosensitivity testing at the single-cell levelChuan Yang, Caibo Yang, Yosef Yarden, et al.
Anti-Cancer Drugs|August 19, 2006
Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophilesKenneth K W To, Steve C F Au-Yeung, Yee-Ping Ho
Journal of Chromatography. A|March 12, 2002
Determination of the release of hydrolyzed demethylcantharidin from novel traditional chinese medicine-platinum compounds with anticancer activity by gas chromatographyKenneth K W To, Yee-Ping Ho, Steve C F Au-Yeung
Expert Opinion on Drug Metabolism & Toxicology|November 25, 2010
The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statinsMiao Hu, Kenneth K W To, Valiant W L Mak, et al.
Molecules (Basel, Switzerland)|April 13, 2023
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic ApplicationsKenneth K W To, Enming Xing, Ross C Larue, et al.
Molecular Carcinogenesis|June 17, 2011
Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cellsKenneth K W To, Le Yu, Shuwen Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 26, 2024
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapyKenneth K W To, Zoufang Huang, Hang Zhang, et al.
Pageof 10